Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models
Antonella Conforti, Emanuele Marra, Fabio Palombo, et al.
Molecular Therapy (2021) Vol. 30, Iss. 1, pp. 311-326
Open Access | Times Cited: 64

Showing 26-50 of 64 citing articles:

A COVID-19 DNA Vaccine Candidate Elicits Broadly Neutralizing Antibodies against Multiple SARS-CoV-2 Variants including the Currently Circulating Omicron BA.5, BF.7, BQ.1 and XBB
Yuan Ding, Feng Fan, Xin Xu, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 778-778
Open Access | Times Cited: 6
Development of T cell antigen-based human coronavirus vaccines against nAb-escaping SARS-CoV-2 variants
Hao Zhou, Ping Leng, Yang Wang, et al.
Science Bulletin (2024) Vol. 69, Iss. 15, pp. 2456-2470
Closed Access | Times Cited: 2
Immunogenicity and protection efficacy of a COVID-19 DNA vaccine encoding spike protein with D614G mutation and optimization of large-scale DNA vaccine production
Aytül Gül, Sedef Erkunt Alak, Hüseyin Can, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Enhancing Immune Responses against SARS-CoV-2 Variants in Aged Mice with INDUK: A Chimeric DNA Vaccine Encoding the Spike S1-TM Subunits
Lishan Cui, Junbiao Wang, Fiorenza Orlando, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34624-34635
Open Access | Times Cited: 2
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2
Selina Pasquero, Francesca Gugliesi, Gloria Griffante, et al.
Antiviral Research (2022) Vol. 200, pp. 105278-105278
Open Access | Times Cited: 9
Optimization of In Vivo Electroporation Conditions and Delivery of DNA Vaccine Encoding SARS-CoV-2 RBD Using the Determined Protocol
D. N. Kisakov, L. A. Kisakova, M. B. Borgoyakova, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2259-2259
Open Access | Times Cited: 9
A linear DNA encoding the SARS-CoV-2 receptor binding domain elicits potent immune response and neutralizing antibodies in domestic cats
Antonella Conforti, Elisa Sanchez, Erika Salvatori, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 28, pp. 238-248
Open Access | Times Cited: 5
Sequential Delivery of Live Attenuated Influenza Vaccine and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Ferret Model Can Reduce SARS-CoV-2 Shedding and Does Not Result in Enhanced Lung Pathology
Kathryn A. Ryan, Katarzyna E. Schewe, Jonathan Crowe, et al.
The Journal of Infectious Diseases (2021) Vol. 225, Iss. 3, pp. 404-412
Open Access | Times Cited: 11
Development of DNA Vaccine Candidate against SARS-CoV-2
Xingyun Wang, Nino Rcheulishvili, Jie Cai, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 1049-1049
Open Access | Times Cited: 8
A linear SARS-CoV-2 DNA vaccine candidate reduces virus shedding in ferrets
Mathias Martins, Gabriela Mansano do Nascimento, Antonella Conforti, et al.
Archives of Virology (2023) Vol. 168, Iss. 4
Open Access | Times Cited: 4
Success of nano-vaccines against COVID-19: a transformation in nanomedicine
Manoj Kumar Sarangi, Sasmita Padhi, Gautam Rath, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 12, pp. 1739-1761
Closed Access | Times Cited: 7
Immunogenicity of novel DNA vaccines encoding receptor‐binding domain (RBD) dimer‐Fc fusing antigens derived from different SARS‐CoV‐2 variants of concern
Ting Zhang, Zhirong Wang, Jiaojiao Yang, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 4
Robust and protective immune responses induced by heterologous prime‐boost vaccination with DNA‐protein dimeric RBD vaccines for COVID‐19
Yaling An, Gan Zhao, Huixin Duan, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Open Access | Times Cited: 4
Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2
Annarita Miluzio, Alessandro Cuomo, Chiara Cordiglieri, et al.
EBioMedicine (2022) Vol. 87, pp. 104390-104390
Open Access | Times Cited: 6
Relevance of Spike/Estrogen Receptor-α interaction for endothelial-based coagulopathy induced by SARS-CoV-2
Silvia Stella Barbieri, Franca Cattani, Leonardo Sandrini, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 3
A trimeric NTD and RBD SARS-CoV-2 subunit vaccine induced protective immunity in CAG-hACE2 transgenic mice and rhesus macaques
Jiaping Yu, Wenrong Yao, Yingsong Hu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 7
DNA-Vaccine-Induced Immune Response Correlates with Lower Viral SARS-CoV-2 Titers in a Ferret Model
Mirco Compagnone, Eleonora Pinto, Erika Salvatori, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1178-1178
Open Access | Times Cited: 4
Immunogenicity and protective efficacy of a DNA vaccine inducing optimal expression of the SARS-CoV-2 S gene in hACE2 mice
Zhuo-xin Li, Sheng Feng, He Zhang, et al.
Archives of Virology (2022) Vol. 167, Iss. 12, pp. 2519-2528
Open Access | Times Cited: 4
Immunogenicity of COVID-eVax Delivered by Electroporation Is Moderately Impacted by Temperature and Molecular Isoforms
Federico D’Alessio, Lucia Lione, Erika Salvatori, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 678-678
Open Access | Times Cited: 2
Design and Immunogenicity of SARS-CoV-2 DNA Vaccine Encoding RBD-PVXCP Fusion Protein
Dmitri Dormeshkin, Mikalai Katsin, Maria Stegantseva, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1014-1014
Open Access | Times Cited: 2
The nuts and bolts of SARS-CoV-2 Spike Receptor Binding Domain heterologous expression
Mariano Maffei, Linda Celeste Montemiglio, Grazia Vitagliano, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
A COVID-19 DNA Vaccine Candidate Elicits Broadly Neutralizing Antibodies Against Multiple SARS-CoV-2 Variants Including the Currently Circulating Omicron BF.5, BF.7, BQ.1 and XBB
Yuan Ding, Feng Fan, Xin Xu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Closed Access | Times Cited: 1
What We Learned about the Feasibility of Gene Electrotransfer for Vaccination on a Model of COVID-19 Vaccine
Urška Kamenšek, Maja Čemažar, Simona Kranjc, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1981-1981
Open Access | Times Cited: 1
Approaches to Improve the Immunogenicity of Plasmid DNA-Based Vaccines against COVID-19
M. B. Borgoyakova, Ekaterina A. Volosnikova, Aleksander Alekseevich Ilyichev, et al.
IntechOpen eBooks (2023)
Open Access | Times Cited: 1
A Phase I, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Trial to Study the Safety and Immunogenicity of a DNA-Based Vaccine Against COVID-19 (COVIGEN) in Healthy SARS-CoV-2 Vaccine-Naïve Participants Aged 18 to 59 Years Old
Nicholas Wood, Ushma Wadia, Peter Richmond, et al.
(2024)
Closed Access

Scroll to top